High expression of APOBEC3C may lead to an increase in macrophages and dendritic cells while decreasing CD8+ T cells, thus contributing to the poor cumulative survival rate of glioma patients (Figure 7B). This evidence concerns the gene CD8A and central nervous system cancer.